Followers | 829 |
Posts | 119634 |
Boards Moderated | 14 |
Alias Born | 09/05/2002 |
Thursday, December 15, 2022 7:06:13 PM
https://finance.yahoo.com/news/guardant-health-announces-positive-results-211600504.html
https://finance.yahoo.com/news/1-guardant-dna-blood-test-220041937.html
GH’s data aren’t bad, but they aren’t as good as those for EXAS’s Cologuard, which is based on a stool sample rather than a blood sample.
EXAS is +24%/AH, adding about $2B(!) to its market cap.
In #msg-168735158 (from May 2022), I said:
“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
Recent GH News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 08:59:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 08:11:54 PM
- Guardant Health Reports First Quarter 2024 Financial Results and Increases 2024 Revenue Guidance • Business Wire • 05/09/2024 08:05:00 PM
- Guardant Health to Participate in Upcoming Investor Conferences • Business Wire • 05/07/2024 08:05:00 PM
- Guardant Health Surpasses 500 Peer-Reviewed Publications Milestone • Business Wire • 05/07/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/06/2024 09:06:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/06/2024 09:05:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/06/2024 09:03:39 PM
- FDA Advisory Panel Review of Guardant Health’s Shield™ Blood Test to Screen for Colorectal Cancer to Be Held on May 23 • Business Wire • 04/22/2024 12:52:00 PM
- Guardant Health to Report First Quarter 2024 Financial Results on May 9, 2024 • Business Wire • 04/18/2024 08:05:00 PM
- Guardant Health to Present Data Highlighting Application of Epigenomics to Advance Precision Oncology at 2024 AACR Annual Meeting • Business Wire • 04/03/2024 12:05:00 PM
- Guardant Health ECLIPSE Study Data Demonstrating Efficacy of Shield Blood-based Test for Colorectal Cancer Screening to be Published in The New England Journal of Medicine • Business Wire • 03/13/2024 09:00:00 PM
- Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 03/06/2024 09:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 01:01:19 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2024 11:39:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2024 11:37:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2024 11:35:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2024 11:34:03 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/04/2024 10:53:35 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/01/2024 10:08:09 PM
- New Survey: Patients and Physicians Overwhelmingly Agree Blood Tests Could Help Close the Colorectal Cancer Screening Gap • Business Wire • 03/01/2024 10:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/28/2024 12:07:27 AM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 02/23/2024 09:10:02 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/22/2024 10:23:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/22/2024 09:10:00 PM
FEATURED POET Announces Design Win and Collaboration with Foxconn Interconnect Technology for High-speed AI Systems • May 14, 2024 10:09 AM
Branded Legacy Inc. Invites Shareholders to Celebrate Milestones at Open House: Announces Share Buyback and Commitment to Authorized Share Count • BLEG • May 15, 2024 8:30 AM
Alliance Creative Group (ACGX) Releases Q1 2024 Financial and Disclosure Report with an 88% increase in Net Income from Q1 2023 to Q1 2024 • ACGX • May 15, 2024 8:30 AM
Category V Biotech, Inc. Announces Letter of Intent to Acquire Genetic Networks, Expanding into Biotechnology Sector • CATV • May 15, 2024 8:00 AM
VAYK Added New Manager for Expansion into $64 Billion Domestic Short-term Rental Market • VAYK • May 14, 2024 9:00 AM
Element79 Gold Corp Reports Exceptionally High-Grade Results from Lucero • ELEM • May 14, 2024 7:00 AM